The fourth lab in Poonen's orbit is NVIDIA, which (like Google) is a Cohesity investor. He said NVIDIA chief executive, ...

I want to have Now Assist generate draft replies for requesters. The easiest way to add functionality not found in standard ...

ServiceNow (NYSE:NOW) disclosed multiple critical flaws in its AI Platform, including a severe SQL injection vulnerability ...

ServiceNow is positioned as a leader in agentic AI, with a broad product portfolio and deep enterprise integration. ServiceNow's agentic AI adoption is accelerating, with AI ACV surpassing $1 billion ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

President Donald Trump has spent weeks telling the courts that his new White House ballroom is a top-secret national security matter. On Thursday night, he invited the communist leader of ...

ServiceNow CEO Bill McDermott joins 'Squawk on the Street' to discuss increasing risks and concerns for AI, how ServiceNow is combating those concerns and more. Got a confidential news tip? We want to ...

A cinematic obsessive with the filmic palate of a starving raccoon, Rob London will watch pretty much anything once. With a mind like a steel trap, he's an endless fount of movie and TV trivia, borne ...

ServiceNow (NOW) crossed $1B in AI ACV with 24% revenue growth, while Palantir (PLTR) posted 93% revenue growth but trades at 65x sales. ServiceNow's 26x forward P/E and a 29% one-year drawdown offer ...

Adobe dropped 2% after its Q4 revenue guidance only bracketed consensus, overshadowing a record $6.76 billion Q3 and 150%+ AI ARR growth. Peers Intuit and ServiceNow barely moved while QQQ gained 0.9% ...

With AI putting the squeeze on SaaS providers, ITSM incumbent ServiceNow is embracing a consumption-based shift and an expansion play centered on cyber. The once stable era of IT service management ...

Women increasingly turning to testosterone therapy to manage menopause symptoms are running into unexpected prescription delays and denials at pharmacies, according to interviews with more than half a ...